Hui; Ho-Wah

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hui; Ho-Wah.The latest application filed is for "formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- ethyl)-2,2-difluoroacetamide".

Company Profile

6.27.32

Hui; Ho-Wah - Basking Ridge NJ
Hui; Ho-Wah - Somerset County NJ US
Hui; Ho-Wah - Libertyville IL
Hui; Ho-Wah - Somerset NJ
Hui; Ho-Wah - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof Grant 11,406,629 - Stahly , et al. August 9, 2	2022-08-09
Formulations Of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20220211686 - Hui; Ho-Wah ; et al.	2022-07-07
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- ethyl)-2,2-difluoroacetamide Grant 11,129,821 - Hui , et al. September 28, 2	2021-09-28
Solid Forms Comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione And A Coformer, Compositions And Methods Of Use Thereof App 20210100785 - Stahly; G. Patrick ; et al.	2021-04-08
Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof Grant 10,835,522 - Stahly , et al. November 17, 2	2020-11-17
Formulations Of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20200237740 - Hui; Ho-Wah ; et al.	2020-07-30
Solid Forms Comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione And A Coformer, Compositions And Methods Of Use App 20190321349 - Stahly; G. Patrick ; et al.	2019-10-24
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- ethyl)-2,2-difluoroacetamide Grant 10,449,187 - Hui , et al. Oc	2019-10-22
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof Grant 10,376,503 - Stahly , et al. A	2019-08-13
Formulations Of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20180353496 - Hui; Ho-Wah ; et al.	2018-12-13
Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- ethyl)-2,2-difluoroacetamide Grant 10,052,315 - Hui , et al. August 21, 2	2018-08-21
Solid Forms Comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione And A Coformer, Compositions And Methods Of Use Thereof App 20180200245 - Stahly; G. Patrick ; et al.	2018-07-19
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof Grant 9,974,780 - Stahly , et al. May 22, 2	2018-05-22
Solid forms comprising 4-amino-1-.beta.-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof Grant 9,968,627 - Stahly , et al. May 15, 2	2018-05-15
Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3- -dihydro-1H-isoindol-4-yl}-amide Grant 9,884,042 - Boersen , et al. February 6, 2	2018-02-06
Solid Forms Comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione And A Coformer, Compositions And Methods Of Use Thereof App 20180000808 - Stahly; G. Patrick ; et al.	2018-01-04
Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof Grant 9,808,450 - Stahly , et al. November 7, 2	2017-11-07
Romidepsin formulations and uses thereof Grant 9,795,650 - Huang , et al. October 24, 2	2017-10-24
Romidepsin formulations and uses thereof Grant 9,782,451 - Huang , et al. October 10, 2	2017-10-10
Solid Forms Comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione And A Coformer, Compositions And Methods Of Use Thereof App 20170258778 - Stahly; G. Patrick ; et al.	2017-09-14
Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3- -dihydro-1H-isoindol-4-yl}-amide Grant 9,757,355 - Chen , et al. September 12, 2	2017-09-12
Formulations Of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)m- Ethyl)-2,2-difluoroacetamide App 20170196847 - Hui; Ho-Wah ; et al.	2017-07-13
Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof Grant 9,695,146 - Stahly , et al. July 4, 2	2017-07-04
Nanosuspension of a poorly soluble drug via microfluidization process Grant 9,616,019 - Chen , et al. April 11, 2	2017-04-11
Romidepsin Formulations And Uses Thereof App 20170007665 - HUANG; Lianfeng ; et al.	2017-01-12
Romidepsin Formulations And Uses Thereof App 20170000845 - HUANG; Lianfeng ; et al.	2017-01-05
Controlled release oral dosage forms of poorly soluble drugs and uses thereof Grant 9,532,977 - Chen , et al. January 3, 2	2017-01-03
Romidepsin Formulations And Uses Thereof App 20160367625 - HUANG; Lianfeng ; et al.	2016-12-22
Romidepsin formulations and uses thereof Grant 9,468,664 - Huang , et al. October 18, 2	2016-10-18
Solid Forms Comprising 4-amino-i-b-d-ribofuranosyl-1,3,5-triazin-2 (1h) -one And A Coformer, Compositions And Methods Of Use Thereof App 20160296546 - STAHLY; G. Patrick ; et al.	2016-10-13
Romidepsin formulations and uses thereof Grant 9,463,215 - Huang , et al. October 11, 2	2016-10-11
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,403,829 - Connolly , et al. August 2, 2	2016-08-02
Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof App 20160128981 - CHEN; Ming J. ; et al.	2016-05-12
Romidepsin Formulations And Uses Thereof App 20160067304 - HUANG; Lianfeng ; et al.	2016-03-10
Romidepsin Formulations And Uses Thereof App 20160067303 - HUANG; Lianfeng ; et al.	2016-03-10
Solid Forms Comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione And A Coformer, Compositions And Methods Of Use Thereof App 20160045483 - STAHLY; G. Patrick ; et al.	2016-02-18
Solid Forms Comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione And A Coformer, Compositions And Methods Of Use Thereof App 20160039785 - STAHLY; G. Patrick ; et al.	2016-02-11
Nanosuspension Of A Poorly Soluble Drug Via Microfluidization Process App 20150265534 - CHEN; Ming J. ; et al.	2015-09-24
Formulations Of Cyclopropanecarboxylic Acid -amide App 20150190374 - Boersen; Nathan ; et al.	2015-07-09
Romidepsin Formulations And Uses Thereof App 20150182584 - HUANG; Lianfeng ; et al.	2015-07-02
Nanosuspension of a poorly soluble drug via microfluidization process Grant 9,023,886 - Chen , et al. May 5, 2	2015-05-05
Romidepsin Formulations And Uses Thereof App 20150051157 - HUANG; Lianfeng ; et al.	2015-02-19
Oral Dosage Forms Of Cyclopropanecarboxylic Acid -amide App 20140093561 - Chen; Ming J. ; et al.	2014-04-03
Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof App 20140018404 - Chen; Ming J. ; et al.	2014-01-16
Method of integrating therapeutic agent into a bioerodible medical device Grant 8,524,148 - Shrivastava , et al. September 3, 2	2013-09-03
Romidepsin Formulations And Uses Thereof App 20130184225 - Huang; Lianfeng ; et al.	2013-07-18
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process App 20110124702 - CHEN; Ming J. ; et al.	2011-05-26
Method Of Integrating Therapeutic Agent Into A Bioerodible Medical Device App 20070189915 - Shrivastava; Sanjay ; et al.	2007-08-16
Prosthesis with multiple drugs applied separately by fluid jet application in discrete unmixed droplets App 20040185081 - Verlee, Donald ; et al.	2004-09-23
Extended release formulations of erythromycin derivatives Grant 6,010,718 - Al-Razzak , et al. January 4, 2	2000-01-04
Topical antibacterial compositions containing penetration enchancers Grant 5,082,656 - Hui , et al. January 21, 1	1992-01-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.